Samsung Corning Precision Glass Co., Ltd.

Genesen Co., Ltd.

Hyeon Jun Shin

Jong Baek Seon

Young Su Chung

Sang Dun Choi

Hyun Tai Jeong

Xiang Ai Gui

Hyuk Kwon Kwon

Sang Heon Hyun

The present invention relates to a fusion polypeptide that inhibits TLR1/2, TLR2/6, TLR7, TLR8 and TLR9 signaling pathways as well as Toll-like receptor 4 (TLR4) and TLR3, and a pharmaceutical composition for preventing or treating TLR pathway mediated diseases. The fusion peptide of the present invention has an excellent effect of inhibiting TLR4 and various TLR pathways and can be effectively used in preventing and treating various TLR pathway mediated diseases caused by the signaling pathways, such as autoimmune diseases, inflammatory diseases and degenerative neurological diseases, by inhibiting the TLR mediated immune responses.

Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising same

A semiconductor thin film using a self-assembled monolayer (SAM) and a method for producing the semiconductor thin film are provided. According to the semiconductor thin film, a uniform inorganic seed layer is formed by using the self-assembled monolayer so that the adhesion between an insulating layer and a semiconductor layer is enhanced and thus the surface tension is reduced, thereby allowing the semiconductor thin film to have high quality without defects.

Semiconductor thin film using self-assembled monolayers and methods of production thereof

Growing community of inventors

Suwon-si, South Korea

Hyeon Jun Shin